Health Plans
Industry Surveys
Events
Departments
- Leadership
- Finance
- Technology
- Physicians
- Community Hospitals
- Health Plans
- Marketing
- Quality
- Nursing
- HR
- Service Lines
Aetna to end payment for a drug in colonoscopies
New York Times, December 28, 2007
Aetna is the latest insurer to clamp down on the use of a powerful anesthetic during an increasingly common form of colon cancer screening. The company will send a letter to doctors, saying that it plans to classify the drug as "medically unnecessary" for most such procedures. As of April 1, Aetna plans to stop paying for its use in those cases. The change by Aetna comes on the heels of similar moves last year by WellPoint and six months ago by Humana. Other insurers say they have no plans to follow their lead, including UnitedHealthcare.
Most Viewed
Most Emailed
- Little-Known Medicare Pay Code Change Will Hurt Specialists
- Obama Plans to Sign Executive Order to Target Medicare Waste, Fraud
- Electronic Medical Records Don't Save Money, Says Study
- Why Do Some Hospitals Successfully Implement EHRs and Others Fail?
- What Breast Cancer Screenings Reveal about Cost Control
- Nursing Department Improves Quality and Patient Satisfaction With Culture Change
- Beware of Medicaid Expansion Pitfalls
- The Foundation of Quality Is Safety
- Chiropractic Care Could Reduce Health Costs, Says Report
- House OKs Bill to Stop Medicare Physician Cuts
